Global Influenza Vaccine Market Has Bright Potential, States Koncept Analytics in Its Research Report Now Available at MarketPublishers.com
07 Feb 2017 • by Natalie Aster
LONDON – Worldwide, the market for influenza vaccines (flu shots) is comparably unaffected and has huge potential in terms of the treatment of any epidemic of an influenza virus. The market in the United States is the world’s dominant market owing to its robust dynamics and a broad innovation scope across the region. The market growth is fuelled by a hike in incidence rates of H1N1 outbreaks, swelling expenditure on national healthcare programmes, development of the market in emerging countries, booming ageing population alongside the increased expenditure on medications and healthcare.
The world influenza vaccine sector is witnessing the development of novel drug products, increase in FDA approvals, use of advanced technologies, and a growing rate of efficiency of flu shots, growing awareness and expanding private-public partnership.
Meantime, certain factors like complex development and sophisticated production process, unclear process for new vaccine introduction and high R&D expenses could be the main challenges to the market growth.
In-demand report “Global Influenza Vaccine Market: Industry Analysis & Outlook (2017-2021)” elaborated by Koncept Analytics offers a shrewd, detailed assessment of the market on a global scale and also presents a detailed regional market assessment.
The study presents an insightful assessment of the world market influenza vaccine market size estimates and forecasts by value; production capacity by indication plus forecasts; and an analysis of the market across the key countries such as the US, Japan and Germany. The report covers the market dynamics examining trends and developments, growth drivers and key challenges as well as other issues faced by the industry. The research limelights the competitive scenario, and includes profiles of the top 4 market players like Novartis AG, Sanofi S.A., GlaxoSmithKline Plc., and AstraZeneca. Forecasts are provided through to 2021-end.
Please, follow to Koncept Analytics page at MarketPublishers.com to find more market research reports by this publisher.